Phase II study of VEGF trap for the treatment of metastatic thyroid cancer

BACKGROUND: Several multi-targeted tyrosine kinase inhibitors (TKIs) have activity in RAI-refractory thyroid cancer. The anti-tumor effect is attributed at least in part to their ability to inhibit angiogenesis in these vascular tumors. VEGF Trap (VT) is a recombinantly-produced fusion protein consi...

Full description

Saved in:
Bibliographic Details
Published in:Cancer
Main Authors: Sherman, Eric J., Dunn, Lara, Ho, Alan L., Baxi, Shrujal, Ghossein, Ronald A., Haque, Sofia, Sima, Cami, Tuttle, Robert Michael, Pfister, David G.
Format: Artigo
Language:Inglês
Published: 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6773269/
https://ncbi.nlm.nih.gov/pubmed/31174237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32046
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items